Voting Results Of Postal Ballot
With reference to our previous letter dated September 28, 2017; we wish to inform you that in accordance to Section 110 of the Companies Act, 2013 ('Act') read with the Companies (Management and Administration) Rules, 2014 as amended from time to time and other applicable provisions of the Act, Postal Ballot Notice and Form dated September 22, 2017; containing Resolutions as enlisted below were sent to the Shareholders of the Company.... Preferential Issue
Please find attached herewith the documents as required for getting the In-principle Approval of BSE Limited for the Equity Shares to be Issued by the Company under Preferential Guidelines. Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fredun Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Half Yearly Compliance Certificate Under Regulation 7(3) Of SEBI Listing Regulations, 2015.
In compliance to Regulation 7(3) of SEBI Listing Regulations, 2015; we furnish hereunder the Certificate, duly signed by the Director of Fredun Pharmaceuticals Limited and by Authorized Representative of 'Purva Sharegistry (India) Pvt. Ltd.', designated Share Transfer Agent of the Company for the half year ended September 30, 2017. Half Yearly Certificate Under Regulations 40(9) & 40(10) Of SEBI Listing Regulations, 2015
In compliance to Regulation 40(9) & 40(10) of SEBI Listing Regulations, 2015; we furnish hereunder the certificate for the half year ended September 30, 2017 of 'Fredun Pharmaceuticals Limited' as issued by Rajendra & Co., Practising Company Secretaries. Preferential Issue
Please find attached herewith the documents as required for getting the In-principle Approval of BSE Limited for the Equity Shares to be Issued by the Company under Preferential Guidelines. Shareholding for the Period Ended September 30, 2017
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here Statement Of Investors Grievances For The Quarter Ended September 30, 2017.
In compliance to Regulation 13(3) of SEBI Listing Regulations, 2015; we hereby furnish a Statement of Investors Grievances for the quarter ended September 30, 2017. Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fredun Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Scrutinizer's Report
Enclosed Scrutinizers report with voting Results for AGM dated 28/09/2017